Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aurora 1:1 Drops (Indica)
- Development stage
- Unknown
- Lead developer
- Aurora Medical Group
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Aurora 1:1 Drops (Indica) is a cannabis-based oil formulation containing a balanced 1:1 ratio of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Developed by the BC Centre on Substance Use (BCCSU) and manufactured by Aurora Cannabis, this product is being evaluated as an adjunct therapy to methadone-based Opioid Agonist Therapy (OAT) for individuals living with opioid use disorder (OUD). The formulation is created by extracting cannabinoids and terpenes from the Indica cannabis plant and diluting the concentrated extract in medium-chain triglyceride (MCT) oil. The therapeutic rationale is that the combination of THC and CBD may help manage opioid withdrawal symptoms and cravings, potentially improving retention in OAT and reducing illicit opioid use.
- Brand names
- Aurora 1:1 Drops (Indica)
- Other names
- 1:1 THC:CBD cannabis oilAurora 1:1 DropsTHC-MMT
02
Targets
CNR2 (Cannabinoid receptor type 2)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))
Beyond the preview
Go deeper on Aurora 1:1 Drops (Indica).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aurora 1:1 Drops (Indica).